SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-076710
Filing Date
2023-06-30
Accepted
2023-06-30 08:26:24
Documents
15
Period of Report
2023-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318880d7_8k.htm   iXBRL 8-K 51029
2 EXHIBIT 99.1 tm2318880d7_ex99-1.htm EX-99.1 18298
7 GRAPHIC tm2318880d7_ex99-1img001.jpg GRAPHIC 2225
  Complete submission text file 0001104659-23-076710.txt   317862

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230630.xsd EX-101.SCH 3996
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230630_def.xml EX-101.DEF 27706
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230630_lab.xml EX-101.LAB 39306
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230630_pre.xml EX-101.PRE 26326
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2318880d7_8k_htm.xml XML 7169
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 231059592
SIC: 2834 Pharmaceutical Preparations